MZE829 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09 (month) in 2mo
ESTIMATED |
READOUT
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · Proteinuric Kidney Disease |
MAZE Maze Therapeutics, Inc. | MZE829 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|